Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Shares Outstanding (Weighted Average) (2016 - 2019)

Historic Shares Outstanding (Weighted Average) for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to $5506.2.

  • Sanofi's Shares Outstanding (Weighted Average) rose 12584.67% to $5506.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $5506.2, marking a year-over-year increase of 12584.67%. This contributed to the annual value of $4701.8 for FY2024, which is 9999.97% down from last year.
  • Latest data reveals that Sanofi reported Shares Outstanding (Weighted Average) of $5506.2 as of Q3 2025, which was up 12584.67% from $2716.7 recorded in Q2 2025.
  • In the past 5 years, Sanofi's Shares Outstanding (Weighted Average) registered a high of $1.4 billion during Q4 2021, and its lowest value of $847.36 during Q1 2024.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $312.1 million, with a median of $2721.0 in 2022.
  • In the last 5 years, Sanofi's Shares Outstanding (Weighted Average) tumbled by 9999.97% in 2024 and then skyrocketed by 12584.67% in 2025.
  • Sanofi's Shares Outstanding (Weighted Average) (Quarter) stood at $1.4 billion in 2021, then decreased by 10.86% to $1.3 billion in 2022, then rose by 5.44% to $1.3 billion in 2023, then tumbled by 100.0% to $4701.8 in 2024, then rose by 17.11% to $5506.2 in 2025.
  • Its Shares Outstanding (Weighted Average) was $5506.2 in Q3 2025, compared to $2716.7 in Q2 2025 and $1451.6 in Q1 2025.